Answer
Yes, the thiazide component of olmesartan medoxomil/hydrochlorothiazide may impair glucose tolerance or reveal latent diabetes mellitus, and patients with diabetes may require adjustments to insulin or oral hypoglycaemic doses.
Sources for this answer
- Olmesartan/Hydrochlorothiazide 20 mg/12.5 mg film-coated tabletsThornton & Ross Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 2Document updated
Sources checked